1. In vivo LNP-CRISPR Approaches for the Treatment of Hemophilia

   • Jeong Hyeon Lee
   • Jeong Pil Han

   Leading Article Open access 28 March 2024 Pages: 239 - 248

   

2. Unwinding Helicase MCM Functionality for Diagnosis and Therapeutics of Replication Abnormalities Associated with Cancer: A Review

   • Arathi Radhakrishnan
   • Ritwik Gangopadhyay
   • Rajpal Srivastav

   Review Article 26 March 2024 Pages: 249 - 264

   

3. Advances in Radioligand Theranostics in Oncology

   • Ismaheel O. Lawal
   • Sofiullah O. Abubakar
   • Mike M. Sathekge

   Review Article 31 March 2024 Pages: 265 - 289

   

4. Lutetium-177 Labelled Anti-PSMA Monoclonal Antibody (Lu-TLX591) Therapy for Metastatic Prostate Cancer: Treatment Toxicity and Outcomes

   • Hanh Nguyen
   • Kathryn Hird
   • Nat P. Lenzo

   Original Research Article Open access 06 March 2024 Pages: 291 - 299

   

5. Identification of Plasmatic MicroRNA-206 as New Predictor of Early Recurrence of Atrial Fibrillation After Catheter Ablation Using Next-generation Sequencing

   • Filip Šustr
   • Táňa Macháčková
   • Jan Novák

   Original Research Article Open access 08 March 2024 Pages: 301 - 310

   

6. Diagnostic Approaches to Investigate JAK2-Unmutated Erythrocytosis Based on a Single Tertiary Center Experience

   • Youngeun Lee
   • Soo Hyun Seo
   • Sang Mee Hwang

   Original Research Article Open access 03 April 2024 Pages: 311 - 318

   

7. Estimating the Prognostic Value of the NTRK Fusion Biomarker for Comparative Effectiveness Research in The Netherlands

   • Irene Santi
   • Heleen Vellekoop
   • Maureen Rutten-van Mölken

   Original Research Article Open access 14 April 2024 Pages: 319 - 328

   

8. Molecular Dynamic Simulations to Determine Individualized Therapy: Tetrabenazine for the GNAO1 Encephalopathy E246K Variant

   • Raffaele Falsaperla
   • Vincenzo Sortino
   • Simone Ronsisvalle

   Original Research Article 06 April 2024 Pages: 329 - 337

   

9. Lifileucel: First Approval

   • Susan J. Keam

   AdisInsight Report 16 April 2024 Pages: 339 - 344

   

10. Comment on “Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta‑Analysis”

    • Jun Ma
    • Wei Han

    Letter to the Editor 10 April 2024 Pages: 345 - 346